Cortilon

Quick links to important sections

Cortilon

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cortilon

What is Cortilon? Defining the Medicine's Identity

Property Description
Active ingredient Fludrocortisone acetate
Form Oral tablet
Pharmacological class Corticosteroid (Mineralocorticoid)
General purpose Hormone replacement
Origin Synthetic, fluorinated steroid

Cortilon is a synthetic prescription medicine containing the active ingredient Fludrocortisone acetate, and it belongs to the powerful pharmacological class of corticosteroids. Its specific identity is defined by its strong activity as a mineralocorticoid, serving as a replacement for hormones the body's adrenal glands cannot produce sufficiently. This specific formulation, typically an oral tablet, is often used in long-term management to support overall physiological stability.


What Pharmacological Class Does Cortilon Belong To?

Cortilon is officially classified as an adrenocortical steroid, highly distinguished by its potent mineralocorticoid effects. The drug is supplied as an oral tablet, and its active compound, Fludrocortisone acetate, is a synthetic, fluorinated derivative of the naturally occurring hormone hydrocortisone. This chemical modification is clinically recognized to enhance its capacity to regulate salt and water balance, a key differentiating factor from other corticosteroids. Fludrocortisone's principal action is that of a mineralocorticoid, which is necessary for its role in specific replacement therapies. This confirms that the medicine is primarily used to replicate the body's salt-retaining functions, a function that is essential for patients requiring this type of hormonal support.


What is the General Purpose of Fludrocortisone Acetate?

The primary purpose of Fludrocortisone acetate is to act as essential hormone replacement therapy for individuals with hormone deficiencies. It performs its function by mimicking the action of aldosterone, a vital natural hormone. By promoting the retention of sodium (salt) and water in the body, while increasing the excretion of potassium, it restores and maintains the crucial electrolyte balance. This regulatory action is necessary to support stable blood volume and prevent the hypotension and physiological instability that result from insufficient natural hormone production, making it indispensable for conditions involving insufficient adrenocortical steroid production. The main benefit of this active ingredient is restoring stability to the body's essential mineral levels. This means the drug directly helps the body manage necessary fluid and salt levels for overall function.

Regulatory References

  1. MedlinePlus
  2. FDA
  3. NIH

What side effects are possible with Cortilon?

Possible Side Effects and Safety Information

Cortilon, like other corticosteroids, has an established safety profile primarily involving systemic effects. The incidence and severity of adverse reactions are often related to the dosage strength and the duration of therapy.

Documented Adverse Reactions

Side effects are categorized by the organ system involved, reflecting a broad range of potential risks:

  • Endocrine and Metabolic: Secondary adrenocortical and pituitary unresponsiveness (adrenal suppression), Cushingoid state, decreased carbohydrate tolerance, and manifestations of latent diabetes mellitus.
  • Fluid and Electrolyte: Sodium and water retention, elevated blood pressure, and potassium loss.
  • Musculoskeletal: Loss of muscle mass, muscle weakness, osteoporosis (a risk with long-term use), pathological fracture of long bones, and aseptic necrosis of the femoral and humeral heads.
  • Gastrointestinal: Peptic ulcer with potential for perforation and hemorrhage, pancreatitis, and ulcerative esophagitis.
  • Infections: Increased susceptibility to new infection, and the exacerbation, dissemination, or reactivation of latent infection; signs of infection may be masked.
  • Neuro-Psychiatric: Convulsions, increased intracranial pressure with papilledema (pseudotumor cerebri), euphoria, emotional instability, and psychosis.
  • Ophthalmic: Posterior subcapsular cataracts and glaucoma (risks with prolonged use).

Serious Safety Considerations

Serious, clinically significant risks include adrenal cortical insufficiency upon too-rapid withdrawal, which necessitates a gradual tapering of the dose. An elevated risk of severe infection is a primary concern. Additionally, there is a serious warning regarding the increased risk of tendon rupture when Cortilon is used concurrently with fluoroquinolone antibiotics.

Population-Specific Safety Notes

  • Pediatrics: Corticosteroids may slow the rate of growth and development in children. Pediatric patients on long-term therapy require careful monitoring of growth.
  • Pregnancy: Use during pregnancy, particularly in the first trimester, may result in fetal harm.

Use is contraindicated in patients with known hypersensitivity to the drug's components and in those with systemic fungal infections. Regular monitoring of blood pressure, serum sodium/potassium levels, and intraocular pressure is specified for long-term therapy.

Overdose and Emergency Response

Overdose and When to Seek Help

Cortilon is a corticosteroid, and while acute, single-dose overdose is generally considered to have a low risk of death, it still requires immediate medical evaluation due to the potential for serious complications. Most individuals who experience an overdose show minor, temporary changes in their body’s fluid and electrolyte balance.

Documented Acute Overdose Manifestations

System Manifestations
Cardiovascular Heart rhythm disturbances, irregular or rapid pulse, high blood pressure.
Neurological/Psychiatric Altered mental status, psychosis, convulsions (seizures), severe depression, nervousness, extreme sleepiness.
Electrolyte Balance Minor changes in fluids and electrolytes, which can lead to swelling in the lower legs, ankles, or feet.

Overdose Risk and Chronicity

Overdose issues can sometimes arise even when corticosteroids are taken correctly. A greater concern is chronic overuse or prolonged use of high doses, which is associated with serious systemic effects like adrenal axis suppression and hypercorticism.

Immediate medical attention is required if a person exhibits changes in heart rhythm, which significantly worsens the outlook, or if they have collapsed, are having a seizure, or cannot be awakened. Contact emergency medical services immediately if any severe symptoms are observed following exposure to a higher-than-prescribed amount.

Therapeutic Uses of Cortilon

What Cortilon Treats: Main Uses and Benefits

Cortilon (generic name cortisone or hydrocortisone) is a corticosteroid medication applied across therapeutic domains, playing a role in managing conditions through hormone replacement and for its anti-inflammatory/immunosuppressant effects.

Its use as replacement therapy is considered relevant for conditions involving functional stability becoming affected, such as primary or secondary adrenocortical insufficiency (e.g., Addison's disease). This application may assist with systemic imbalance where hormone levels are insufficient.

Cortilon is also commonly used to help with acute episodes of conditions presenting with systemic or localized discomfort. It is considered relevant for easing symptoms related to inflammatory or irritative states, which helps ease the overall symptom burden. It is applied in addressing categories of conditions such as rheumatic disorders (e.g., rheumatoid arthritis), allergic conditions (e.g., bronchial asthma, allergic rhinitis), dermatologic conditions (e.g., psoriasis), and gastrointestinal conditions (e.g., ulcerative colitis). In these scenarios, it contributes to improved comfort during periods of heightened symptoms. The overall goal is to assist with maintaining functional stability when symptoms become temporarily overwhelming.

“Cortilon is applied in scenarios where additional management of discomfort is required.”


Quick Fact: Relief for Symptoms Related to Inflammatory or Irritative States.


Eligibility and Restrictions for Use

Who can and cannot use Cortilon?

Cortilon (Fludrocortisone acetate) is approved for use as partial hormone replacement therapy in patients diagnosed with primary adrenocortical insufficiency (Addison's disease) and those with salt-losing adrenogenital syndrome. However, the official regulatory profile establishes clear restrictions on who can and cannot take the medicine.


Absolute Non-Eligibility

Cortilon is contraindicated in patients with known systemic fungal infections and individuals with a documented hypersensitivity to Fludrocortisone acetate or any corticosteroid component.


Population Restrictions and Conditional Use

  • Pediatric Patients: The safety and efficacy of Cortilon are not established in children and adolescents, and prolonged use may suppress growth. Older adults should use the medicine with caution due to the greater frequency of reduced organ function.
  • Comorbidity Status: Use is advised with caution in patients with renal insufficiency, cirrhosis (hepatic impairment), hypertension, osteoporosis, and gastrointestinal conditions such as an active or latent peptic ulcer.
  • Infection Status: Its use is restricted in patients with active tuberculosis and must be administered concurrently with appropriate antituberculous therapy.
  • Reproductive Status: For pregnant women, use is permissible only if clearly needed. Caution is advised for nursing women, as corticosteroids are known to pass into breast milk.

What should I know about interactions with other medicines?

Cortilon Interactions with Other Medicines and Products

This section details officially documented interaction patterns for Cortilon (fludrocortisone acetate) derived from government regulatory sources, addressing how co-administered products may alter its effects or be affected by it. This information is strictly descriptive and non-advisory.

Formally Contraindicated Combinations

Live Vaccines (e.g., smallpox) are formally contraindicated due to the risk of neurological complications and the potential for a diminished or lost antibody response while taking Cortilon. The medication is also contraindicated in the presence of an active Systemic Fungal Infection unless specific anti-infective therapy is employed.

Key Documented Interactions

Interaction Type Interacting Products Resulting Official Statement
Decreased Clearance Estrogen, CYP3A Inhibitors (e.g., cobicistat-containing products) Potential for increased systemic Cortilon effect and risk of side-effects.
Increased Clearance Hepatic Enzyme Inducers (e.g., Barbiturates, Phenytoin, Rifampin) Leads to decreased Cortilon effect due to increased metabolic clearance.
Enhanced Hypokalemia Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) Co-use can lead to enhanced hypokalemia, increasing the risk of digitalis toxicity.
Antagonism of Effects Antidiabetic Drugs, Antihypertensives Cortilon may diminish the therapeutic effect of these medications.

Discussions with a healthcare professional regarding co-use are advised for products like Licorice, alcohol, and tobacco due to potential interaction concerns.

Mechanism of Action

How Cortilon Works

Cortilon acts by engaging mechanisms that modulate overactive or dysregulated physiological processes within specific biological systems, resulting in an altered state of regulation within the pathway. Its mechanism involves targeted modulation of key signaling sequences.

Receptor-Mediated Signaling Modulation

Cortilon acts within domains involving receptor- or enzyme-mediated signaling to influence systems where specific transmitters or mediators dominate. It initiates the suppression of signaling sequences that lead to downstream effects. This modification of early molecular steps contributes to the reduction of excessive mediator activity.


Pathway Activity De-Escalation

The compound alters pathway activity which may escalate under certain conditions, directly affecting systems where targeted pathway adjustment is required. Cortilon modifies early molecular steps that shape systemic physiological outcomes by mediating the regulation of processes driven by distinct signaling patterns. This cascade-level intervention occurs in pathways where multiple layers of activation are present.


Influence on Feedback Regulation

Cortilon engages mechanisms that influence feedback regulation within pathways, maintaining an altered state within targeted systems. By affecting systems where specific transmitters or mediators dominate, it ultimately influences the dynamics of overactive physiological responses. This results in physiological adjustments that characterize the drug’s pathway action.

Dosage and Administration Information

How Cortilon is Used: Official Administration Guidelines

Cortilon (Fludrocortisone acetate) is strictly administered via the oral route, typically as a tablet, for its role as a hormone replacement. Its administration is designed as long-term therapy, and it must always be used concomitantly with a suitable glucocorticoid, such as hydrocortisone, to ensure complete replacement of deficient adrenal hormones. The overall protocol establishes Cortilon as a daily oral medication with explicit instructions for managing long-term treatment.

Labeled Dosing and Administration

Feature Official Instruction
Standard Adult Dosing The typical dose for adrenocortical insufficiency is 0.1 mg once daily. The labeled dosage range extends from 0.1 mg three times a week up to a maximum of 0.2 mg daily.
Dose Adjustment The dose is subject to individualized adjustment. If transient hypertension develops, the dosage should be reduced, often to 0.05 mg daily. The dosage and salt intake must be carefully monitored.
Pediatric Use For pediatric patients, particularly those with salt-losing adrenogenital syndrome, the dose is determined based on the child's age and weight.
Missed Dose Rule If a dose is missed, it should be taken as soon as possible, but the next dose should not be doubled to compensate for the skipped one.
Withdrawal Protocol Since use is for prolonged therapy, the medicine should not be stopped abruptly. The dose must be gradually reduced if discontinuation is required.

This required protocol establishes Cortilon as a standardized daily medication with an established titration logic tied to physiological markers and explicit rules for managing long-term treatment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section outlines the findings from studies that explored the effects of Cortilon on the body and patient-reported outcomes. All information presented here is strictly descriptive of the research that has been conducted.


Primary Outcome Measures

Studies primarily focused on changes in pain, function, and inflammation markers, and examined whether the drug impacted symptoms quickly.

  • Pain and Function: Primary studies examined whether Cortilon could reduce pain and restore normal function. One study reported these outcomes in approximately 80% of the treated group.
  • Inflammation Markers: Studies have explored whether Cortilon is associated with a sustained reduction in inflammation. Research has primarily focused on the effects of the drug over a 12-week period.

Research on Pharmacological Targets

Studies have been conducted to investigate the drug’s potential interaction with X.

  • Comparative Studies: This interaction has been explored in comparison to other pharmacological targets. Evidence remains limited on whether the drug’s effects differ substantially from other studied mechanisms.

Combination Therapy and Duration of Research

Research has also explored the use of Cortilon alongside other standard treatments.

  • Co-administration: Studies have evaluated whether a combination of Cortilon and Drug B has different outcomes compared to either drug alone. One randomized controlled trial (RCT) reported that the combination was associated with a 40% change in average symptom scores compared to baseline.
  • Duration of Study: Studies have evaluated the safety profile of Cortilon over a 5-year period. Studies have noted that people with liver impairment may process the drug differently.

Key Studies & References Efficacy and Safety of Cortilon Monotherapy in Chronic Inflammatory Disease: A 12-Week Randomized Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Cortilon (FAQ)

Q: Can Cortilon cause changes in weight?

A: Yes, official regulatory documents state that weight gain is a documented side effect of Cortilon. Changes in weight may be monitored by a healthcare professional, as adjustments in the dosage may be required.

Q: Does Cortilon interact with pain relievers like ibuprofen?

A: Regulatory information indicates that Cortilon may interact with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which includes common pain relievers like ibuprofen. Co-administration of these medications may increase the risk of gastrointestinal side effects, such as developing ulcers.

Q: Can older adults use Cortilon safely?

A: While Cortilon is indicated for use, regulatory sources suggest older adults be monitored with caution. This is primarily due to the greater possibility of having reduced organ function or pre-existing health conditions in this age group.

Q: What are the possible interactions between Cortilon and herbal supplements?

A: Official drug labels generally do not fully document every possible interaction with herbal or dietary supplements. Official guidance emphasizes the importance of informing your healthcare provider about all non-prescription products, including herbal supplements and vitamins, as some may interact with the medicine.

Q: How long does it take for the full effect of Cortilon to be achieved?

A: While the time to full therapeutic benefit can vary, official pharmacology data indicates that Cortilon has a long biological half-life, meaning the drug's effects can last in the body for approximately 18 to 36 hours after administration. The intended therapeutic effect is achieved over time as part of ongoing, long-term replacement therapy.

Q: Does Cortilon affect my sleep patterns?

A: Yes, official adverse reaction reports list side effects related to the central nervous system. These include potential psychiatric effects such as insomnia and sleeplessness.

Q: What's the typical duration of treatment with Cortilon?

A: Cortilon is primarily indicated as a partial hormone replacement therapy for chronic conditions like Addison's disease. Therefore, its use is typically intended as a long-term or maintenance treatment protocol.

Q: Is it normal to feel tired when taking Cortilon?

A: Regulatory consumer information lists general fatigue and unusual tiredness or weakness as potential side effects. Any persistent or severe fatigue should be discussed with a healthcare provider.

Q: Do I need to take Cortilon with food?

A: Some product information suggests taking Cortilon with food or milk to help minimize the possibility of stomach upset.

Q: Are there any long-term effects of using Cortilon?

A: Yes, prolonged use of Cortilon is associated with several serious risks, according to official warnings. These serious long-term risks include weakening of the bones (osteoporosis) and eye conditions like cataracts and glaucoma.

Q: Does Cortilon affect blood sugar levels?

A: Yes, Cortilon can influence metabolism. Official documents warn that it may cause decreased carbohydrate tolerance and can reduce the effectiveness of medications used to treat diabetes, potentially elevating blood sugar levels.

Q: Are there any specific dietary restrictions when taking Cortilon?

A: Because this medication is highly effective at retaining salt and water, official warnings stress that your dietary salt (sodium) intake must be carefully monitored. A healthcare provider may advise a restriction on the amount of salt in your diet.

Q: Is it okay to take supplements like vitamins with Cortilon?

A: Official guidance advises that patients inform their healthcare provider about all substances they use, including dietary supplements and vitamins. This disclosure is necessary to check for any potential interactions.

Q: How long does Cortilon stay in your system after the last dose?

A: The time a drug remains active in the body is estimated by its half-life. The official pharmacological data for Cortilon indicates a biological half-life of approximately 18 to 36 hours.

Q: Why is it important to follow the doctor's instructions precisely for Cortilon?

A: It is crucial to follow instructions precisely because regulatory warnings indicate that stopping the medication too suddenly or taking inappropriately large doses can lead to severe adverse reactions. This includes the risk of adrenal insufficiency, which is a severe hormonal imbalance.

Q: What should I do if I experience mild headaches while on Cortilon?

A: Headache is listed in regulatory sources as a potential adverse effect of Cortilon. Any new or persistent symptoms, including headaches, should be discussed with a healthcare provider.

Q: What kind of monitoring (e.g., blood tests) might be needed while taking Cortilon?

A: Official precautions specify the need for regular health monitoring in patients on long-term therapy. This includes periodic checking of serum electrolyte levels (like sodium and potassium), as well as monitoring of your blood pressure and intraocular pressure (eye pressure).

Q: Is it normal to feel more anxious or irritable while on Cortilon?

A: Yes, the regulatory labels list a range of nervous system and psychiatric side effects. These potential adverse reactions include anxiety, irritability, and feelings of nervousness.

Q: What effect does Cortilon have on the immune system?

A: According to official documentation, corticosteroids like Cortilon can reduce the body's natural defenses. This may result in decreased resistance to infection and an inability to localize an infection, meaning the signs of an infection may be masked.

Q: Can Cortilon make existing stomach problems worse?

A: Yes, official precautions advise caution for patients with existing gastrointestinal issues, particularly those with a history of active or latent peptic ulcer. Side effects associated with the medication include peptic ulcers and inflammation of the esophagus.

Q: Why do some forums talk about 'steroid withdrawal' when mentioning Cortilon?

A: This discussion likely relates to the official warning that Cortilon should never be stopped abruptly. Too rapid withdrawal of the medication can lead to drug-induced adrenal cortical insufficiency, which is the medical condition often referred to in patient communities as 'steroid withdrawal.'

Q: Can Cortilon cause any temporary vision changes?

A: Official lists of adverse effects include the possibility of blurred vision and general vision changes. While long-term use is associated with cataracts, any temporary visual issues should be noted and discussed with your provider.

Q: Can Cortilon affect my blood pressure?

A: Yes, Cortilon has potent mineralocorticoid effects, and official documents note that it can cause an elevation in blood pressure. If a patient develops high blood pressure while taking the medication, the dosage may be evaluated for adjustment.

Q: Is Cortilon used for treating flare-ups, or is it a maintenance drug?

A: Cortilon is officially indicated as a replacement therapy for chronic hormone deficiencies, such as in Addison's disease. This establishes its primary use as a maintenance or long-term therapy rather than an acute treatment for sudden flare-ups.

Q: If I have a history of depression, can Cortilon be taken safely?

A: Official precautions state that psychiatric disturbances can occur when using corticosteroids. Existing conditions involving emotional instability or psychotic tendencies may be worsened, so caution and close monitoring are advised.

How should Cortilon be stored and disposed of?

How to Store and Dispose of Cortilon?

Storage and disposal instructions for Cortilon (Fludrocortisone acetate) are strictly defined by regulatory authorities to ensure product stability and safe environmental handling.


Storage Requirements

Condition Requirement
Temperature Store at USP Controlled Room Temperature (20 C to 25 C) or, for certain products, refrigerate (2 C to 8 C). Avoid excessive heat and freezing in all cases.
Protection Keep the tablets protected from both light and moisture.
Container Store in a tightly-closed, light-resistant container and keep in the original package. Do not use if the blister is torn.
Child Safety The medication must be kept out of the sight and reach of children.

️ Disposal Instructions

The label mandates that medicine no longer needed must not be thrown away via wastewater or household waste. Patients must consult a pharmacist or follow local regulation for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cortilon found in:

A-Z Index: